{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:54:26Z","timestamp":1790852066934,"version":"4.1.0"},"reference-count":50,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Ketoacidosis is a critical adverse event requiring close clinical monitoring. Based on the Adverse Event Reporting System (FAERS) database of the U.S. Food and Drug Administration (FDA), this study aimed to identify the drugs with the closest association and the highest signal strength with the risk of drug\u2010induced ketoacidosis by performing disproportionality analysis, thereby providing a reference for clinical medication safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adverse event data from the first quarter of 2004 to the second quarter of 2025 were retrieved from the FAERS database. Preferred Terms (PTs) related to \u2018ketoacidosis\u2019 in the Medical Dictionary for Regulatory Activities (MedDRA) were used as outcome indicators. The generic names of drugs were standardized with reference to the DrugBank database. Disproportionality analysis was conducted using the Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR) and Information Component (IC) of Bayesian Confidence Propagation Neural Network and the time trend of drug\u2010induced ketoacidosis was analysed by combining the Time\u2010to\u2010Onset (TTO) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 22\u2009375\u2009298 adverse event reports were included in this study, among which 6977 were related to ketoacidosis. The top 5 drugs with the highest number of reports were metformin, quetiapine, empagliflozin, canagliflozin and dapagliflozin in sequence; whereas the top 5 drugs with the highest ROR values were dapagliflozin, dapagliflozin\u2010saxagliptin, ipragliflozin, ertugliflozin\u2010sitagliptin and empagliflozin. Among the top 50 drugs ranked by ROR, 36 (72%) had no mention of ketoacidosis risk in their package inserts. TTO analysis showed that the incidence frequency of ketoacidosis induced by quetiapine, olanzapine, aripiprazole, pembrolizumab, empagliflozin\/linagliptin and nivolumab remained stable with the duration of medication; the incidence frequency induced by tirzepatide and alpelisib increased gradually over time; while that induced by empagliflozin, canagliflozin and other drugs decreased gradually with time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The high\u2010risk drugs for inducing ketoacidosis are mainly sodium\u2010glucose cotransporter 2 (SGLT2) inhibitors (e.g., dapagliflozin and empagliflozin), followed by psychotropic drugs (e.g., quetiapine). Attention should also be paid to the potential risk of ketoacidosis induced by some drugs that do not mention this adverse reaction in their package inserts. The findings of this study can provide data support for clinical medication monitoring and the revision of drug package inserts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.70790","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:23:11Z","timestamp":1776748991000},"page":"5893-5906","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drug\u2010Associated Ketoacidosis: A Comprehensive Disproportionality Analysis Based on the\n                    <scp>FAERS<\/scp>\n                    Database"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6943-485X","authenticated-orcid":false,"given":"Pengqiang","family":"Du","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Fuwai Central China Cardiovascular Hospital Central China Fuwai Hospital of Zhengzhou University  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy The Second Affiliated Hospital of Luohe Medical College  Luohe China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinpeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy The Ninth People's Hospital of Zhengzhou  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Fuwai Central China Cardiovascular Hospital Central China Fuwai Hospital of Zhengzhou University  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital  Taiyuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-138513"},{"key":"e_1_2_12_3_1","volume-title":"Treasure Island (FL) Ineligible Companies. Disclosure: Amit Dhamoon Declares no Relevant Financial Relationships With Ineligible Companies","author":"Ghimire P.","year":"2025"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i5.514"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573399812666160421121307"},{"key":"e_1_2_12_6_1","article-title":"Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature","volume":"6","author":"Lucero P.","year":"2018","journal-title":"Case Reports in Critical Care"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-247921"},{"issue":"8","key":"e_1_2_12_8_1","article-title":"A Case of Euglycemic Diabetic Ketoacidosis: SGLT2 Inhibitor Complication Triggering Acute Coronary Syndrome and Cardiac Arrest Post Coronary Artery Bypass Grafting (CABG)","volume":"17","author":"Nteka F.","year":"2025","journal-title":"Cureus"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.30773\/pi.2023.0301"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/10401230209147399"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2022.2016696"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0061-7"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74744-3"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0165-1"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.007"},{"issue":"12","key":"e_1_2_12_16_1","first-page":"S197","article-title":"Diabetic Ketoacidosis: Risk Factors, Mechanisms and Management Strategies in Sub\u2010Saharan Africa: A Review","volume":"82","author":"Otieno C. F.","year":"2005","journal-title":"East African Medical Journal"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020214"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2924"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/20420986231181334"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1145587"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa200"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4320-5"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.11824"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-025-04377-7"},{"issue":"5","key":"e_1_2_12_25_1","article-title":"Precipitating Risk Factors, Clinical Presentation, and Outcome of Diabetic Ketoacidosis in Patients With Type 1 Diabetes","volume":"11","author":"Ahuja W.","year":"2019","journal-title":"Cureus"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/15209156251390828"},{"issue":"5","key":"e_1_2_12_27_1","first-page":"337","article-title":"Diabetic Ketoacidosis: Evaluation and Treatment","volume":"87","author":"Westerberg D. P.","year":"2013","journal-title":"American Family Physician"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-2344"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110041"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-022-02015-6"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-23-0245"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1054"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1990.tb01462.x"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.64719\/pb.4092"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2275704"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003461"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2024-004124"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2025.101697"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1881"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00331-0"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0322c"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111336"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2024.05.014"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.12890\/2024_004357"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1397029"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-025-01749-x"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2024.01.004"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2024.10.002"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2886"},{"issue":"4","key":"e_1_2_12_50_1","article-title":"The Study of Different Clinical Pattern of Diabetic Ketoacidosis and Common Precipitating Events and Independent Mortality Factors","volume":"11","author":"Mahesh M. G.","year":"2017","journal-title":"Journal of Clinical and Diagnostic Research"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0320"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.70790","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.70790","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.70790","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:32:50Z","timestamp":1786087970000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/10.1111\/dom.70790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1111\/dom.70790"],"URL":"https:\/\/doi.org\/10.1111\/dom.70790","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.70790\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70790\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70790\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70790\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70790\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70790\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70790\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70790\/v1\/review2","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"2026-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}